Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / January / Rebuilding the Lacrimal Blueprint
Research & Innovations Anterior Segment News

Rebuilding the Lacrimal Blueprint

Autophagy: an unexpected gatekeeper of lacrimal gland development

1/15/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology and Regenerative Medicine

Leading institutions in ophthalmology and stem cell research employ advanced human embryonic stem cell models and organoid technology to study lacrimal gland biology, combining molecular biology, regenerative medicine, and translational research to explore novel therapeutic strategies.

  • #1

    Stanford University School of Medicine

    Stanford, CA

    Stanford is a leader in ocular regenerative medicine and stem cell research, with pioneering work in organoid models and translational approaches to dry eye disease and lacrimal gland dysfunction.

    Key Differentiators

    • Ophthalmology
    • Stem Cell Biology
    • Regenerative Medicine
  • #2

    Massachusetts Eye and Ear Infirmary / Harvard Medical School

    Boston, MA

    Harvard-affiliated Massachusetts Eye and Ear is renowned for clinical and basic science research in ocular surface diseases and lacrimal gland pathophysiology, integrating molecular insights with patient care.

    Key Differentiators

    • Ophthalmology
    • Cellular Biology
    • Translational Research
  • #3

    Johns Hopkins University School of Medicine

    Baltimore, MD

    Johns Hopkins has a strong focus on ocular surface disorders and regenerative therapies, with expertise in stem cell-derived organoids and molecular mechanisms of lacrimal gland development.

    Key Differentiators

    • Ophthalmology
    • Stem Cell Research
    • Molecular Biology
  • #4

    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    UCSF is recognized for its innovative research in ocular surface diseases and stem cell biology, contributing to understanding lacrimal gland dysfunction and developing novel regenerative treatments.

    Key Differentiators

    • Ophthalmology
    • Stem Cell Biology
    • Clinical Research
  • #5

    Moorfields Eye Hospital / UCL Institute of Ophthalmology

    London, N/A

    Moorfields and UCL are internationally recognized for their cutting-edge research in ocular regenerative medicine and stem cell applications, including lacrimal gland biology and dry eye disease.

    Key Differentiators

    • Ophthalmology
    • Regenerative Medicine
    • Stem Cell Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: